These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2968700)

  • 41. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanism of immunosuppression in long surviving (LS) monkey allograft recipients.
    Thomas J; Carver M; Cunningham P; Saldanha C; Thomas F
    Transplant Proc; 1989 Feb; 21(1 Pt 1):388-90. PubMed ID: 2650156
    [No Abstract]   [Full Text] [Related]  

  • 43. Induction of unresponsiveness to skin and heart allografts in mice by a synergistic treatment with procarbazine, antilymphocyte serum, and donor-type cells.
    Floersheim GL
    Transplantation; 1973 Feb; 15(2):195-205. PubMed ID: 4146168
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of posttransplant injection of peripheral blood lymphocytes on skin graft prolongation in mice treated with antilymphocyte serum (ALS) or ALS plus donor bone marrow.
    Gozzo JJ; Hartner WC; Monaco AP; De Fazio SR
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1409-10. PubMed ID: 3274341
    [No Abstract]   [Full Text] [Related]  

  • 45. Cardiac xenotransplantation in primates.
    Sadeghi AM; Robbins RC; Smith CR; Kurlansky PA; Michler RE; Reemtsma K; Rose EA
    J Thorac Cardiovasc Surg; 1987 Jun; 93(6):809-14. PubMed ID: 3553747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Skin allograft survival following intrathymic injection of donor bone marrow.
    Cober SR; Randolph MA; Lee WP
    J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclosporine-induced transplantation unresponsiveness in rat cardiac allograft recipients: in vitro determination of helper and suppressor activity.
    Uhteg LC; Salomon DR; Rocher LL; Kupiec-Weglinski JW; Araujo JL; Rubin MF; Tilney NL; Carpenter CB
    J Immunol; 1985 Sep; 135(3):1800-5. PubMed ID: 3160780
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of graft inoculation with donor bone marrow cells on kidney allograft survival in antilymphocyte serum-treated rats.
    Otsu I; Gottschalk R; Monaco AP
    Transplant Proc; 1994 Oct; 26(5):3060. PubMed ID: 7940962
    [No Abstract]   [Full Text] [Related]  

  • 49. Immunosuppression by cyclosporine in vivo need not block effector T-cell function in mice.
    Auchincloss H
    Transplant Proc; 1989 Feb; 21(1 Pt 1):860. PubMed ID: 2650285
    [No Abstract]   [Full Text] [Related]  

  • 50. Specific unresponsiveness to skin allografts in mice. V. Synergy between donor tissue extract, procarbazine hydrochloride, and antilymphocyte serum in creating a long-lasting unresponsiveness mediated by suppressor T cells.
    Brent L; Opara SC
    Transplantation; 1979 Feb; 27(2):120-6. PubMed ID: 380069
    [No Abstract]   [Full Text] [Related]  

  • 51. Mouse skin graft prolongation with donor-strain bone marrow and antilymphocyte serum. Effect of bone marrow cell storage.
    De Fazio SR; Hartner WC; Monaco AP; Gozzo JJ
    Transplantation; 1986 Jan; 41(1):26-8. PubMed ID: 3510490
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute and chronic graft-versus-host disease in man.
    Sullivan KM
    Int J Cell Cloning; 1986; 4 Suppl 1():42-93. PubMed ID: 2943828
    [No Abstract]   [Full Text] [Related]  

  • 53. Phenotypic and functional alterations of recipient lymphocytes after transfusion of UV-irradiated and normal blood--implications for marrow transplantation.
    Deeg HJ; Aprile J; Severns E; Rajantie J; Schmidt E; Raff RF; Green KE; Storb R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2709-14. PubMed ID: 2950640
    [No Abstract]   [Full Text] [Related]  

  • 54. [Cyclosporin A].
    Thiele HG
    Immun Infekt; 1984 Jun; 12(3):157-62. PubMed ID: 6398798
    [No Abstract]   [Full Text] [Related]  

  • 55. Cyclosporine.
    Thomas SE; Gordon DS
    South Med J; 1986 Feb; 79(2):205-14. PubMed ID: 2418510
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyclosporin as an adjunct to the induction of specific unresponsiveness.
    Kahan BD
    Ann Inst Pasteur Immunol; 1987; 138(4):618-21. PubMed ID: 2960330
    [No Abstract]   [Full Text] [Related]  

  • 57. Splenectomy antagonizes the action of cyclosporine.
    Morris RE; Hoyt G; Baldwin J; Meiser B
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1079-80. PubMed ID: 2968696
    [No Abstract]   [Full Text] [Related]  

  • 58. Tolerance induction in adult animals. The ciclosporin anomaly.
    Lafferty KJ; Gill R; Babcock S
    Prog Allergy; 1986; 38():247-57. PubMed ID: 2941764
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunosuppression with cyclosporine. A new approach to improve patency of venous allografts.
    Bandlien KO; Toledo-Pereyra LH; MacKenzie GH; Choudhury SP; Cortez JA
    Arch Surg; 1983 Jul; 118(7):829-33. PubMed ID: 6860131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The influence of pretransplant and posttransplant immunosuppression on cardiac graft survival in the donor-specific transfusion model in mice. Comparison of the effects of cyclophosphamide, procarbazine, cyclosporine, and cortisone.
    Lasek W; Jakóbisiak M; Grochowska M; Górecki D; Gniadecki R; Kaliński P
    Transplantation; 1989 May; 47(5):913-5. PubMed ID: 2655232
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.